An experimental lung cancer drug has extended patients’ life expectancy by more than 50% in preliminary trials. Patients given the drug AS1404 on top of standard chemotherapy lived an average of 14 months compared with 8.8 months if given chemotherapy alone.>>> Discuss This Story
